This webinar featured presentations by lead researchers working on some of Australia’s most promising cancer research projects.Professor Phil Hogg provided an update on the work he and his team have been doing at the ACRF Tumour Metabolism Laboratory which focuses on the role of nutrient metabolism particularly in tumours of the Lung, Liver, Breast, Prostate, Colon and Pancreas.
The lab was established with a grant awarded in 2016, thanks to the generosity of our supporters. It continues to support researchers in better understanding the way cancer cells metabolise dietary nutrients.
Professor Paul Keall also presented on the work being done at the ACRF Image-X Institute, which aims to eradicate cancer through innovation in imaging and targeted x-ray therapy. Image-X was established in 2014 with a $2.5 million grant from ACRF. Each of the researchers answered questions submitted by attendees during the webinar. If you’d like to join us at our next webinar, please email email@example.com
Professor Phil Hogg Head, ACRF Centenary Cancer Research Centre at Centenary Institute
Prof Philip Hogg graduated with a PhD in biochemistry from the University of Queensland in 1987. Following post-doctoral training in the USA and Sweden, he returned to UNSW as a NHMRC RD Wright Fellow. He is currently a NHMRC Senior Principal Research Fellow and was the inaugural director of the Lowy Cancer Research Centre at UNSW. He has won several national and international awards for his research, which focuses on a fundamental chemical modification of proteins he discovered. This research has led to a potential new cancer diagnostic and a therapeutic that are in clinical testing.
Professor Paul Keall, Director, The ACRF Image X Institute @University of Sydney
Prof. Keall graduated with his B.Sc. from the University of Waikato, and an M.Sc. and Ph.D. from the University of Adelaide. His career has taken him to positions at Queensland University of Technology, Liverpool Cancer Therapy Centre, and Virginia Commonwealth University. Prior to his current role, he was the Director of the Radiation Physics Division at Stanford University. At the University of Sydney Prof. Keall and his team of 20+ scientists have the mission to create, share and apply novel cancer imaging and targeted radiotherapy methods that improve human health.